Skip to content

New Trustees appointed to the Rosalind Franklin Institute’s Board

Share
Copied link to clipboard!

The Rosalind Franklin Institute has appointed four new trustees: Malcolm Skingle, Hilary Newiss, Bruce Pritchard and Caroline Carter.

The Rosalind Franklin Institute is a national research institute developing new technologies to tackle important health research challenges. Funded by UK Research and Innovation through the Engineering and Physical Sciences Research Council (EPSRC), the Franklin aims to bring about a revolution in imaging which will allow us to see entire cells and tissues in new ways.

Our new trustees come from a diverse range of backgrounds, with a wealth of expertise and skills which will be a great asset to the Franklin. Their experience from the pharmaceutical and biotechnology industries, higher education and government organisations will help support the Franklin’s mission to advance technologies for the Life Sciences.

Professor Paul Matthews, Director of the Franklin, said, “I am delighted to welcome our new trustees to the Franklin Board. Each one of the new board members are individually extraordinary, and we believe that together they will help to propel the Franklin forward to reach our goals.”

About the Trustees

Malcolm Skingle worked for GSK for almost 30 years as their Academic Liaison, working at the interface with academia. Malcolm has recently retired from GSK and has since taken on a portfolio of science related activities.  He is a seasoned private company Chair and Non-Executive Director with Remuneration and Chair of Audit Committee experience.

Hilary Newiss is an experienced Non-Executive Director in the fields of science, innovation, and health, particularly on the intersection between science and society. She currently Chairs the British Science Association and sits on the Boards of the Intellectual Property Office and the Cell and Gene Therapy Catapult.

Bruce Pritchard is a Chartered Accountant, who has mainly worked in the Pharmaceutical and Biotechnology fields. Most recently he was CEO of Liminal Biosciences Inc. He also has extensive experience as Chair and Non-Executive Director with Remuneration and Chair of Audit Committee experience. 

Caroline Carter is a non-practicing solicitor of the senior courts. Since leaving private practice she has held a number of positions within Higher Education, including Council member at Cranfield University and most recently as Executive Dean at the post graduate campus of the University of Law, London. She is also a board member of the Quality Assurance Agency for HE, and involved in a number of HE social mobility and access bodies.

The Franklin thanks our retiring trustees, Ewan McKendrick, Stephen Dauncey and Nora de Leeuw, for their service to the Franklin. They have all played an important role in helping establish the Franklin and contributed to its early success.

Dame Vivienne Cox, Chair of the Board, said, “We have recently sought approval from our Members to tighten the board governance arrangements at the Franklin, and this has given us the opportunity to recruit new independent Trustees.  With Paul Mathews arrival earlier this year we look forward to developing and implementing our new strategy, and these Trustees have the skills and experience to make a valuable contribution. I look forward to working closely with them all.”

We will be announcing additional new trustees early in the new year.